Flexible Ureteroscopy With and Without Ureteral Access Sheath in Treatment of Large Renal Stones

Sponsor
New Valley University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06122129
Collaborator
(none)
84
1
2
4.8
17.6

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the flexible ureteroscope (FURS) technique with and without ureteral access sheath (UAS).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Flexible ureteroscope with ureteral access sheath
  • Procedure: Flexible ureteroscope without ureteral access sheath
N/A

Detailed Description

Treating a large renal stone, more than 2 cm, is changing during the last decades. Technological innovations have led to a significant improvement in flexible ureteroscopes over recent years.

Many authors have used flexible ureteroscope (FURS) with laser fragmentation as proved treating modality with high efficacy. Although percutaneous extraction of large renal stones is still the first option, it has higher and more severer complications than flexible ureteroscopy.

FURS has developed into a standard diagnostic and treatment modality for upper urinary stone disease, transitional cell carcinoma and ureteral strictures. Indeed, more recently FURS is becoming a minimally invasive competitor to percutaneous nephrolithotomy for larger kidney stones as well as an accepted modality for localized treatment of small upper urinary tract transitional cell carcinoma.

The use of ureteral access sheath (UAS) is widely recognized as a technique utilized to keep the intrarenal pressure low when performing FURS for larger and more complex stones, although some authors advocate its use for most renal stones. UASs are now produced with varying characteristics including various lengths, diameters, materials, dilator tip designs, radiopaque markers, and stiffness. However, it also rises surgical costs and may injure the ureteral wall.

Most common reasons cited by urologists for using a UAS are to facilitate repeated entrance into the ureter and collecting system (as a time-saver), lower intrarenal pressure and protection of ureteroscope and ureter when extracting stone fragments. UAS has encouraged urologists in the fragmentation of large stones; it facilitates multiple entries and stone extraction during FURS.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Flexible Ureteroscopy With and Without Ureteral Access Sheath in Treatment of Large Renal Stones: a Randomized Controlled Trial.
Actual Study Start Date :
Nov 8, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Flexible ureteroscope with ureteral access sheath

Stones will be treated by flexible ureteroscope with ureteral access sheath

Procedure: Flexible ureteroscope with ureteral access sheath
The flexible ureteroscope either directly or via an access sheath, depending on the size of the ureter, a 9.5/11.5 Fr or a 12 Fr access sheath will be used.

Active Comparator: Flexible ureteroscope without ureteral access sheath

Stones will be treated by flexible ureteroscope without ureteral access sheath

Procedure: Flexible ureteroscope without ureteral access sheath
Ureteroscopy will be carried out without a ureteral access sheath

Outcome Measures

Primary Outcome Measures

  1. Operative time [Intraperatively]

    Time from sterilization till the end of surgery

Secondary Outcome Measures

  1. Stone-free rate [28 days after intervention]

    Stone-free status was defined as no residual stones or residual stones with a maximum diameter ≤ 4 mm with no clinical symptoms at 1 month after the procedure

  2. Complications [28 days after intervention]

    Complications such as mucosal lacerations, bleeding, urosepsis, and stein Strasse.

  3. Duration of stay [28 days after intervention]

    Time from admission till hospital discharge

  4. Number of patients who need ancillary procedures [28 days after intervention]

    Need for Ancillary Procedures if there was residual.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years old.

  • Both sexes.

  • Patients with upper ureter and renal stones scheduled for flexible ureteroscope.

Exclusion Criteria:
  • Patients with associated distal ureteral stone, kidney transplant or any kind of urinary diversion.

  • Larger stones (11 cm) where the routine use of an access sheath will be felt appropriate to aid multiple passes of the scope.

  • Known ureteric strictures.

  • Concomitant ureteric stones.

  • Patients with narrow ureter where ureteral access sheath was anticipated to be difficult.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New Valley University New Valley Egypt 72511

Sponsors and Collaborators

  • New Valley University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Waheed Fawzy Abdelrasol, Lecturer of Urology, faculty of medicine, New Vally University, New Valley University
ClinicalTrials.gov Identifier:
NCT06122129
Other Study ID Numbers:
  • 0739-20233
First Posted:
Nov 8, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2023